Literature DB >> 22215051

Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?

Polyzois Makras, Stergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos, Athanasios Papatheodorou, Gregory A Kaltsas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22215051      PMCID： PMC3255574          DOI： 10.1038/mt.2011.239

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Authors:  Tricia L Peters; Kenneth L McClain; Carl E Allen
Journal:  Mol Ther       Date:  2011-06-07       Impact factor: 11.454

2.  IL-17A in LCH: systemic biomarker, local factor, or none of the above?

Authors:  Michael D Hogarty
Journal:  Mol Ther       Date:  2011-08       Impact factor: 11.454

Review 3.  Langerhans cell histiocytosis in adults.

Authors:  J S Malpas
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

4.  Reduced bone mineral density in adult patients with Langerhans cell histiocytosis.

Authors:  Polyzois Makras; Evangelos Terpos; George Kanakis; Athanasios Papatheodorou; Athanasios D Anastasilakis; Panagiotis Kokkoris; Gregory A Kaltsas
Journal:  Pediatr Blood Cancer       Date:  2011-05-05       Impact factor: 3.167

5.  Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion.

Authors:  Fabienne Coury; Nicola Annels; Aymeric Rivollier; Selma Olsson; Alessandra Santoro; Carole Speziani; Olga Azocar; Monique Flacher; Sophia Djebali; Jacques Tebib; Maria Brytting; R Maarten Egeler; Chantal Rabourdin-Combe; Jan-Inge Henter; Maurizio Arico; Christine Delprat
Journal:  Nat Med       Date:  2007-12-23       Impact factor: 53.440

6.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307
  6 in total
  6 in total

Review 1.  Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

Authors:  Marie-Luise Berres; Miriam Merad; Carl E Allen
Journal:  Br J Haematol       Date:  2014-11-28       Impact factor: 6.998

2.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

Review 3.  Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.

Authors:  Marie-Luise Berres; Carl E Allen; Miriam Merad
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 4.  Merkel cell polyomavirus and Langerhans cell neoplasm.

Authors:  Ichiro Murakami; Noriko Wada; Junko Nakashima; Mitsuko Iguchi; Makoto Toi; Yumiko Hashida; Tomonori Higuchi; Masanori Daibata; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Yasushi Horie; Keiko Nagata; Kazuhiko Hayashi; Takashi Oka; Tadashi Yoshino; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert
Journal:  Cell Commun Signal       Date:  2018-08-22       Impact factor: 5.712

5.  Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis.

Authors:  Selma Olsson Åkefeldt; Mohamad Bachar Ismail; Alexandre Belot; Giulia Salvatore; Nathalie Bissay; Désirée Gavhed; Maurizio Aricò; Jan-Inge Henter; Hélène Valentin; Christine Delprat
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

Review 6.  Bone metabolism in Langerhans cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Marina Tsoli; Gregory Kaltsas; Polyzois Makras
Journal:  Endocr Connect       Date:  2018-07-02       Impact factor: 3.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.